Acetaminophen inhibits spinal prostaglandin E2 release after peripheral noxious stimulation

Anesthesiology

Volumn 91, Issue 1, 1999, Pages 231-239

  Muth Selbach, Uta S ^b   Tegeder, Irmgard ^a   Brune, Kay ^c   Geisslinger, Gerd ^a  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c NONE

Author keywords

Eicosanoids; Nociception; Paracetamol; Spinal nociceptive processing

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; FORMALDEHYDE; PARACETAMOL; PROSTAGLANDIN; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTINOCICEPTION; ARTICLE; DOSE RESPONSE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; RAT; SPINAL CORD;

ACETAMINOPHEN; ANALGESICS, NON-NARCOTIC; ANIMALS; DINOPROSTONE; MALE; PAIN; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD;

EID: 0032982775     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-199907000-00032     Document Type: Article

References (41)

1. Clissold SP: Paracetamol and phenacetin. Drugs 1986; 4:46-59
2. Brune K: Spinal cord effects of antipyretic analgesics. Drugs 1994; 5:21-7
3. Mitchell JA, Akarasereenont P, Thiemermann C, Flower RJ, Vane JR: Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci U S A 1993; 90:11693-7
4. Riendeau D, Charleson S, Cromlish W, Mancini JA, Wong E, Guay J: Comparison of the cyclooxygenase-1 inhibitory properties of non-steroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors, using sensitive microsomal and platelet assays. Can J Physiol Pharmacol 1997; 75:1088-95
5. McCormack K: Non-steroidal anti-inflammatory drugs and spinal nociceptive processing. Pain 1994; 59:9-43
6. Bannwarth B, Demotes-Mainard F, Schaeverbeke T, Labat L, Dehais J: Central analgesic effects of aspirin-like drugs. Fundam Clin Pharmacol 1995; 9:1-7
7. Bjorkman R: Central antinociceptive effects of non-steroidal anti-inflammatory drugs and paracetamol. Experimental studies in the rat. Acta Anaesthesiol Scand Suppl 1995; 103:1-44
8. Bannwarth B, Netter P, Lapicque F, Gillet P, Pere P, Boccard E, Royer RJ, Gaucher A: Plasma and cerebrospinal fluid concentrations of paracetamol after a single intravenous dose of propacetamol. Br J Clin Pharmacol 1992; 34:79-81
9. Pini LA, Vitale G, Ottani A, Sandrini M: Naloxone-reversible antinociception by paracetamol in the rat. J Pharmacol Exp Ther 1997; 280:934-40
10. Pelissier T, Alloui A, Caussade F, Dubray C, Cloarec A, Lavarenne J, Eschalier A: Paracetamol exerts a spinal antinociceptive effect involving an indirect interaction with 5-hvdroxytryptamine3 receptors: In vivo and in vitro evidence. J Pharmacol Exp Ther 1996; 278:8-14
11. Tjolsen A, Lund A, Hole K: Antinociceptive effect of paracetamol in rats is partly dependent on spinal serotonergic systems. Eur J Pharmacol 1991; 193:193-201
12. Alloui A, Pelissier T, Dubray C, Lavarenne J, Eschalier A: Tropisetron inhibits the antinociceptive effect of intrathecally administered paracetamol and serotonin. Fundam Clin Pharmacol 1996; 10:406-7
13. Hunskaar S, Fasmer OB, Hole K: Acetylsalicylic acid, paracetamol and morphine inhibit behavioral responses to intrathecally administered substance P or capsaicin. Life Sci 1985; 37:1835-41
14. Bjorkman R, Hallman KM, Hedner J, Hedner T, Henning M: Acetaminophen blocks spinal hyperalgesia induced by NMDA and substance P. Pain 1994; 57:259-64
15. Flower RT, Vane JR: Inhibition of prostaglandin synthetase in brain explains the anti-pyretic activity of paracetamol (4-acetamidophenol). Nature 1972; 240:410-1
16. Ferreira SH, Lorenzetti BB, Correa FM: Central and peripheral antialgesic action of aspirin-like drugs. Eur J Pharmacol 1978; 53: 39-48
17. 2 levels in mouse brain. Eur J Pharmacol 1990; 179:25-34
18. Beiche F, Scheuerer S, Brune K, Geisslinger G, Goppelt-Struebe M: Up-regulation of cyclooxygenase-2 mRNA in the rat spinal cord following peripheral inflammation. FEBS Lett 1996; 390:165-9
19. 2 and amino acids evoked by paw formalin injection: A microdialysis study in unanesthetized rats. J Neurosci 1995; 15:2768-76
20. 2 during the first phase in the formalin assay of the rat. Life Sci 1997; 60:PL295-300
21. Tjolsen A, Berge OG, Hunskaar S, Rosland JH, Hole K: The formalin test: An evaluation of the method. Pain 1992; 51:5-17
22. Ungerstedt U: Microdialysis - Principles and applications for studies in animals and man. J Intern Med 1991; 230:365-73
23. Skilling SR, Smullin DH, Beitz AJ, Larson AA: Extracellular amino acid concentrations in the dorsal spinal cord of freely moving rats following veratridine and nociceptive stimulation. J Neurochem 1988; 51:127-32
24. Sauernheimer C, Williams KM, Brune K, Geisslinger G: Application of microdialysis to the pharmacokinetics of analgesics: Problems with reduction of dialysis efficiency in vivo. J Pharmacol Toxicol Methods 1994; 32:149-54
25. Elmquist WF, Sawchuk RJ: Application of microdialysis in pharmacokinetic studies. Pharm Res 1997; 14:267-88
26. Sorkin LS, Hughes MG, Liu D, Willis WDJr, McAdoo DJ: Release and metabolism of 5-hydroxytryptamine in the cat spinal cord examined with microdialysis. J Pharmacol Exp Ther 1991; 257:192-9
27. Klimscha W, Tong C, Eisenach JC: Intrathecal alpha 2-adrenergic agonists stimulate acetylcholine and norepinephrine release from the spinal cord dorsal horn in sheep. An in vivo microdialysis study. ANESTHESIOLOGY 1997; 87:110-6
28. Bouaziz H, Tong C, Yoon Y, Hood DD, Eisenach JC: Intravenous opioids stimulate norepinephrine and acetylcholine release in spinal cord dorsal horn. Systematic studies in sheep and an observation in a human. ANESTHESIOLOGY 1996; 84:143-54
29. 2 is noradrenergic terminal-dependent. Neurosci Lett 1990; 115:253-8
30. Glenn EM, Bowman BJ, Rohloff NA. Anti-inflammatory and PG inhibitory effects of phenacetin and acetaminophen. Agents Actions 1977; 7:513-6
31. Skoglund LA, Eidsaunet W, Pettersen N: The anti-oedematous efficacy of oxindanac equals that of paracetamol in acute postoperative inflammation; Are weak cyclooxygenase inhibitors more effective than strong inhibitors? Int J Clin Pharmacol Res 1989; 9:371-5
32. Tolman EL, Fuller BL, Marinan BA, Capotola RJ, Levinson SL, Rosenthale ME: Tissue selectivity and variability of effects of acetaminophen on arachidonic acid metabolism. Prostaglandins Leukot Med 1983; 12:347-56
33. Lanz R, Polster P, Brune K: Antipyretic analgesics inhibit prostaglandin release from astrocytes and macrophages similarly. Eur J Pharmacol 1986; 130:105-9
34. Malmberg AB, Yaksh TL: Hyperalgesia mediated by spinal glutamate or substance P receptor blocked by spinal cyclooxygenase inhibition. Science 1992; 257:1276-9
35. Whelton A: Renal effects of over-the-counter analgesics. J Clin Pharmacol 1995; 35:454-63
36. Stichtenoth DO, Tsikas D, Gutzki FM, Frolich JC: Effects of ketoprofen and ibuprofen on platelet aggregation and prostanoid formation in man. Eur J Clin Pharmacol 1996; 51:231-4
37. Bippi H, Frolich JC: Effects of acetylsalicylic acid and paracetamol alone and in combination on prostanoid synthesis in man. Br J Clin Pharmacol 1990; 29:305-10
38. 2 secretion and excretion in conscious dogs. Am J Physiol 1979; 236:F552-8
39. Malmberg AB, Yaksh TL: Antinociceptive actions of spinal non-steroidal anti-inflammatory agents on the formalin test in the rat. J Pharmacol Exp Ther 1992; 263:136-46
40. Meller ST, Gebhart GF: Spinal mediators of hyperalgesia. Drugs 1994; 5:10-20
41. Eisenach J: Update on spinal cord pharmacology in pain. Acta Anaesthesiol Scand Suppl 1997; 110:124-6